レジオネラ検査市場：検査タイプ別、用途別、エンドユーザー別、地域別、機会、予測、2017年～2031年

世界のレジオネラ検査の市場規模は、2024年～2031年の予測期間中に7.51％のCAGRで拡大し、2023年の3億5,130万米ドルから2031年には6億2,700万米ドルに成長すると予測されています。市場の成長を後押ししているのは、レジオネラ症、肺炎、ポンティアック熱の有病率の増加、感染予防におけるレジオネラ検査の重要性に対する意識の高まり、製品ポートフォリオの強化に向けた各市場企業の取り組みの高まりです。

レジオネラ菌は、温水浴槽、冷却塔、配管網などの水システムで繁殖します。そのため、ホスピタリティ、商業不動産、ヘルスケア、製造業など、さまざまな業界が定期的なレジオネラ検査に投資しています。そのため、さまざまな地域で商業用不動産セクターが拡大し、市場に有利な成長機会がもたらされています。インドの商業用不動産セクターは、2024年には少なくとも7～8％の成長が見込まれています。

さまざまな規制機関や政府は、定期的な水質検査を促進するために厳しいガイドラインや規制を導入するなど、イニシアチブを活発化させており、これはレジオネラ検査市場の主要な世界動向のひとつです。規制基準が存在することで、特に老人ホーム、ホテル、病院、工業地帯の周辺地域では、汚染リスクを軽減するための水管理計画が確実に実施されます。

市場拡大を後押しするその他の要因としては、免疫学、分子生物学、微生物学の進歩が挙げられます。これらの分野における進歩は、より特異的で感度が高く、迅速なレジオネラ検査法の開発に役立っています。また、レジオネラ菌による汚染の早期発見を可能にし、アウトブレイクを防止するための様々な機関による迅速な介入を保証しています。ホスピタリティセクターの急速な拡大も、観光客の安全確保に向けた取り組みの増加により、市場拡大にプラスの影響を与えています。

当レポートでは、世界のレジオネラ検査市場について調査し、市場の概要とともに、検査タイプ別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界のレジオネラ検査市場の見通し、2017年～2031年

• 市場規模と予測
• 検査タイプ別
• 用途別
• エンドユーザー別
• 地域別
• 企業別市場シェア（％）、2023年

第5章 世界のレジオネラ検査市場の見通し（地域別、2017年～2031年）

• 北米
• 欧州
• アジア太平洋
• 南米
• 中東・アフリカ

第6章 2023年の市場マッピング

第7章 マクロ環境と産業構造

• 供給需要分析
• 輸出入分析
• バリューチェーン分析
• PESTEL分析
• ポーターのファイブフォース分析

第8章 市場力学

第9章 規制枠組みとイノベーション

第10章 主要参入企業の情勢

第11章 価格分析

第12章 ケーススタディ

第13章 主要参入企業の見通し

• BioMerieux SA
• Thermo Fisher Scientific Inc.
• Eurofins Scientific SE
• Becton, Dickinson and Company
• Qiagen NV
• Aquacert Ltd.
• Merck KgaA
• Abbott Laboratories
• Pro Lab Diagnostics Inc.
• IDEXX Laboratories, Inc.

第14章 戦略的提言

第15章 お問い合わせと免責事項

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1.Global Legionella Testing Market, By Value, in USD Billion, 2017-2031F
• Figure 2.Global Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
• Figure 3.Global Legionella Testing Market Share (%), By Test Type, 2017-2031F
• Figure 4.Global Legionella Testing Market Share (%), By Applications, 2017-2031F
• Figure 5.Global Legionella Testing Market Share (%), By End-user, 2017-2031F
• Figure 6.Global Legionella Testing Market Share (%), By Region, 2017-2031F
• Figure 7.North America Legionella Testing Market, By Value, in USD Billion, 2017-2031F
• Figure 8.North America Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
• Figure 9.North America Legionella Testing Market Share (%), By Test Type, 2017-2031F
• Figure 10.North America Legionella Testing Market Share (%), By Applications, 2017-2031F
• Figure 11.North America Legionella Testing Market Share (%), By End-user, 2017-2031F
• Figure 12.North America Legionella Testing Market Share (%), By Country, 2017-2031F
• Figure 13.United States Legionella Testing Market, By Value, in USD Billion, 2017-2031F
• Figure 14.United States Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
• Figure 15.United States Legionella Testing Market Share (%), By Test Type, 2017-2031F
• Figure 16.United States Legionella Testing Market Share (%), By Applications, 2017-2031F
• Figure 17.United States Legionella Testing Market Share (%), By End-user, 2017-2031F
• Figure 18.Canada Legionella Testing Market, By Value, in USD Billion, 2017-2031F
• Figure 19.Canada Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
• Figure 20.Canada Legionella Testing Market Share (%), By Test Type, 2017-2031F
• Figure 21.Canada Legionella Testing Market Share (%), By Applications, 2017-2031F
• Figure 22.Canada Legionella Testing Market Share (%), By End-user, 2017-2031F
• Figure 23.Mexico Legionella Testing Market, By Value, in USD Billion, 2017-2031F
• Figure 24.Mexico Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
• Figure 25.Mexico Legionella Testing Market Share (%), By Test Type, 2017-2031F
• Figure 26.Mexico Legionella Testing Market Share (%), By Applications, 2017-2031F
• Figure 27.Mexico Legionella Testing Market Share (%), By End-user, 2017-2031F
• Figure 28.Europe Legionella Testing Market, By Value, in USD Billion, 2017-2031F
• Figure 29.Europe Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
• Figure 30.Europe Legionella Testing Market Share (%), By Test Type, 2017-2031F
• Figure 31.Europe Legionella Testing Market Share (%), By Applications, 2017-2031F
• Figure 32.Europe Legionella Testing Market Share (%), By End-user, 2017-2031F
• Figure 33.Europe Legionella Testing Market Share (%), By Country, 2017-2031F
• Figure 34.Germany Legionella Testing Market, By Value, in USD Billion, 2017-2031F
• Figure 35.Germany Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
• Figure 36.Germany Legionella Testing Market Share (%), By Test Type, 2017-2031F
• Figure 37.Germany Legionella Testing Market Share (%), By Applications, 2017-2031F
• Figure 38.Germany Legionella Testing Market Share (%), By End-user, 2017-2031F
• Figure 39.France Legionella Testing Market, By Value, in USD Billion, 2017-2031F
• Figure 40.France Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
• Figure 41.France Legionella Testing Market Share (%), By Test Type, 2017-2031F
• Figure 42.France Legionella Testing Market Share (%), By Applications, 2017-2031F
• Figure 43.France Legionella Testing Market Share (%), By End-user, 2017-2031F
• Figure 44.Italy Legionella Testing Market, By Value, in USD Billion, 2017-2031F
• Figure 45.Italy Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
• Figure 46.Italy Legionella Testing Market Share (%), By Test Type, 2017-2031F
• Figure 47.Italy Legionella Testing Market Share (%), By Applications, 2017-2031F
• Figure 48.Italy Legionella Testing Market Share (%), By End-user, 2017-2031F
• Figure 49.United Kingdom Legionella Testing Market, By Value, in USD Billion, 2017-2031F
• Figure 50.United Kingdom Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
• Figure 51.United Kingdom Legionella Testing Market Share (%), By Test Type, 2017-2031F
• Figure 52.United Kingdom Legionella Testing Market Share (%), By Applications, 2017-2031F
• Figure 53.United Kingdom Legionella Testing Market Share (%), By End-user, 2017-2031F
• Figure 54.Russia Legionella Testing Market, By Value, in USD Billion, 2017-2031F
• Figure 55.Russia Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
• Figure 56.Russia Legionella Testing Market Share (%), By Test Type, 2017-2031F
• Figure 57.Russia Legionella Testing Market Share (%), By Applications, 2017-2031F
• Figure 58.Russia Legionella Testing Market Share (%), By End-user, 2017-2031F
• Figure 59.Netherlands Legionella Testing Market, By Value, in USD Billion, 2017-2031F
• Figure 60.Netherlands Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
• Figure 61.Netherlands Legionella Testing Market Share (%), By Test Type, 2017-2031F
• Figure 62.Netherlands Legionella Testing Market Share (%), By Applications, 2017-2031F
• Figure 63.Netherlands Legionella Testing Market Share (%), By End-user, 2017-2031F
• Figure 64.Spain Legionella Testing Market, By Value, in USD Billion, 2017-2031F
• Figure 65.Spain Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
• Figure 66.Spain Legionella Testing Market Share (%), By Test Type, 2017-2031F
• Figure 67.Spain Legionella Testing Market Share (%), By Applications, 2017-2031F
• Figure 68.Spain Legionella Testing Market Share (%), By End-user, 2017-2031F
• Figure 69.Turkey Legionella Testing Market, By Value, in USD Billion, 2017-2031F
• Figure 70.Turkey Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
• Figure 71.Turkey Legionella Testing Market Share (%), By Test Type, 2017-2031F
• Figure 72.Turkey Legionella Testing Market Share (%), By Applications, 2017-2031F
• Figure 73.Turkey Legionella Testing Market Share (%), By End-user, 2017-2031F
• Figure 74.Poland Legionella Testing Market, By Value, in USD Billion, 2017-2031F
• Figure 75.Poland Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
• Figure 76.Poland Legionella Testing Market Share (%), By Test Type, 2017-2031F
• Figure 77.Poland Legionella Testing Market Share (%), By Applications, 2017-2031F
• Figure 78.Poland Legionella Testing Market Share (%), By End-user, 2017-2031F
• Figure 79.South America Legionella Testing Market, By Value, in USD Billion, 2017-2031F
• Figure 80.South America Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
• Figure 81.South America Legionella Testing Market Share (%), By Test Type, 2017-2031F
• Figure 82.South America Legionella Testing Market Share (%), By Applications, 2017-2031F
• Figure 83.South America Legionella Testing Market Share (%), By End-user, 2017-2031F
• Figure 84.South America Legionella Testing Market Share (%), By Country, 2017-2031F
• Figure 85.Brazil Legionella Testing Market, By Value, in USD Billion, 2017-2031F
• Figure 86.Brazil Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
• Figure 87.Brazil Legionella Testing Market Share (%), By Test Type, 2017-2031F
• Figure 88.Brazil Legionella Testing Market Share (%), By Applications, 2017-2031F
• Figure 89.Brazil Legionella Testing Market Share (%), By End-user, 2017-2031F
• Figure 90.Argentina Legionella Testing Market, By Value, in USD Billion, 2017-2031F
• Figure 91.Argentina Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
• Figure 92.Argentina Legionella Testing Market Share (%), By Test Type, 2017-2031F
• Figure 93.Argentina Legionella Testing Market Share (%), By Applications, 2017-2031F
• Figure 94.Argentina Legionella Testing Market Share (%), By End-user, 2017-2031F
• Figure 95.Asia-Pacific Legionella Testing Market, By Value, in USD Billion, 2017-2031F
• Figure 96.Asia-Pacific Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
• Figure 97.Asia-Pacific Legionella Testing Market Share (%), By Test Type, 2017-2031F
• Figure 98.Asia-Pacific Legionella Testing Market Share (%), By Applications, 2017-2031F
• Figure 99.Asia-Pacific Legionella Testing Market Share (%), By End-user, 2017-2031F
• Figure 100.Asia-Pacific Legionella Testing Market Share (%), By Country, 2017-2031F
• Figure 101.India Legionella Testing Market, By Value, in USD Billion, 2017-2031F
• Figure 102.India Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
• Figure 103.India Legionella Testing Market Share (%), By Test Type, 2017-2031F
• Figure 104.India Legionella Testing Market Share (%), By Applications, 2017-2031F
• Figure 105.India Legionella Testing Market Share (%), By End-user, 2017-2031F
• Figure 106.China Legionella Testing Market, By Value, in USD Billion, 2017-2031F
• Figure 107.China Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
• Figure 108.China Legionella Testing Market Share (%), By Test Type, 2017-2031F
• Figure 109.China Legionella Testing Market Share (%), By Applications, 2017-2031F
• Figure 110.China Legionella Testing Market Share (%), By End-user, 2017-2031F
• Figure 111.Japan Legionella Testing Market, By Value, in USD Billion, 2017-2031F
• Figure 112.Japan Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
• Figure 113.Japan Legionella Testing Market Share (%), By Test Type, 2017-2031F
• Figure 114.Japan Legionella Testing Market Share (%), By Applications, 2017-2031F
• Figure 115.Japan Legionella Testing Market Share (%), By End-user, 2017-2031F
• Figure 116.Australia Legionella Testing Market, By Value, in USD Billion, 2017-2031F
• Figure 117.Australia Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
• Figure 118.Australia Legionella Testing Market Share (%), By Test Type, 2017-2031F
• Figure 119.Australia Legionella Testing Market Share (%), By Applications, 2017-2031F
• Figure 120.Australia Legionella Testing Market Share (%), By End-user, 2017-2031F
• Figure 121.Vietnam Legionella Testing Market, By Value, in USD Billion, 2017-2031F
• Figure 122.Vietnam Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
• Figure 123.Vietnam Legionella Testing Market Share (%), By Test Type, 2017-2031F
• Figure 124.Vietnam Legionella Testing Market Share (%), By Applications, 2017-2031F
• Figure 125.Vietnam Legionella Testing Market Share (%), By End-user, 2017-2031F
• Figure 126.South Korea Legionella Testing Market, By Value, in USD Billion, 2017-2031F
• Figure 127.South Korea Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
• Figure 128.South Korea Legionella Testing Market Share (%), By Test Type, 2017-2031F
• Figure 129.South Korea Legionella Testing Market Share (%), By Applications, 2017-2031F
• Figure 130.South Korea Legionella Testing Market Share (%), By End-user, 2017-2031F
• Figure 131.Indonesia Legionella Testing Market, By Value, in USD Billion, 2017-2031F
• Figure 132.Indonesia Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
• Figure 133.Indonesia Legionella Testing Market Share (%), By Test Type, 2017-2031F
• Figure 134.Indonesia Legionella Testing Market Share (%), By Applications, 2017-2031F
• Figure 135.Indonesia Legionella Testing Market Share (%), By End-user, 2017-2031F
• Figure 136.Philippines Legionella Testing Market, By Value, in USD Billion, 2017-2031F
• Figure 137.Philippines Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
• Figure 138.Philippines Legionella Testing Market Share (%), By Test Type, 2017-2031F
• Figure 139.Philippines Legionella Testing Market Share (%), By Applications, 2017-2031F
• Figure 140.Philippines Legionella Testing Market Share (%), By End-user, 2017-2031F
• Figure 141.Middle East & Africa Legionella Testing Market, By Value, in USD Billion, 2017-2031F
• Figure 142.Middle East & Africa Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
• Figure 143.Middle East & Africa Legionella Testing Market Share (%), By Test Type, 2017-2031F
• Figure 144.Middle East & Africa Legionella Testing Market Share (%), By Applications, 2017-2031F
• Figure 145.Middle East & Africa Legionella Testing Market Share (%), By End-user, 2017-2031F
• Figure 146.Middle East & Africa Legionella Testing Market Share (%), By Country, 2017-2031F
• Figure 147.Saudi Arabia Legionella Testing Market, By Value, in USD Billion, 2017-2031F
• Figure 148.Saudi Arabia Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
• Figure 149.Saudi Arabia Legionella Testing Market Share (%), By Test Type, 2017-2031F
• Figure 150.Saudi Arabia Legionella Testing Market Share (%), By Applications, 2017-2031F
• Figure 151.Saudi Arabia Legionella Testing Market Share (%), By End-user, 2017-2031F
• Figure 152.UAE Legionella Testing Market, By Value, in USD Billion, 2017-2031F
• Figure 153.UAE Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
• Figure 154.UAE Legionella Testing Market Share (%), By Test Type, 2017-2031F
• Figure 155.UAE Legionella Testing Market Share (%), By Applications, 2017-2031F
• Figure 156.UAE Legionella Testing Market Share (%), By End-user, 2017-2031F
• Figure 157.South Africa Legionella Testing Market, By Value, in USD Billion, 2017-2031F
• Figure 158.South Africa Legionella Testing Market, By Volume, in No. of tests (Million Units), 2017-2031F
• Figure 159.South Africa Legionella Testing Market Share (%), By Test Type, 2017-2031F
• Figure 160.South Africa Legionella Testing Market Share (%), By Applications, 2017-2031F
• Figure 161.South Africa Legionella Testing Market Share (%), By End-user, 2017-2031F
• Figure 162.By Test Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 163.By Applications Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 164.By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 165.By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Global legionella testing market is projected to witness a CAGR of 7.51% during the forecast period 2024-2031F, growing from USD 351.3 million in 2023 to USD 627 million in 2031F. The market growth is boosted by the increasing prevalence of legionellosis, pneumonia, and Pontiac fever, growing awareness about the importance of legionella testing in preventing infections, and rising efforts by various market players towards enhancing their product portfolio.

The legionella bacteria thrive in water systems such as hot tubs, cooling towers, and plumbing networks. Therefore, various industries, including hospitality, commercial real estate, healthcare, and manufacturing, are investing in regular legionella testing as they understand the activity's benefits and crucial role in maintaining the safety and health of the customers and occupants. Hence, expanding the commercial real estate sector in various regions provides lucrative growth opportunities for the market. India's commercial real estate sector is expected to grow at least 7-8% in 2024.

Various regulatory bodies and governments are taking increasing initiatives, including introducing stringent guidelines and regulations to promote regular water testing, which are among the key global legionella testing market trends. The presence of regulatory standards ensures that water management plans are implemented to mitigate the risk of contamination, especially in areas surrounding nursing homes, hotels, hospitals, and industrial areas.

Other factors bolstering the market expansion include immunology, molecular biology, and microbiology advancements. Advancements in these arenas have aided in the development of legionella testing methods that are more specific and sensitive as well as rapid. They also allow for early detection of contamination by legionella, ensuring prompt intervention by various agencies to prevent outbreaks. The rapid expansion of the hospitality sector is also positively influencing market expansion due to an increase in efforts towards ensuring the safety of the tourists.

Increase in Legionella Related Illnesses Boosts the Global Legionella Testing Market Demand

The legionella bacteria are found in water systems and reservoirs and are responsible for causing various diseases, including Pontiac fever and pneumonia. Legionnaires' disease has an incubation period of two to ten days. According to the estimates of the World Health Organization (WHO), 60-70% of the reported cases are of males, and 75-80% are over fifty years of age. The increasing prevalence of hospital-acquired legionella is further propelling market demand. Regular testing helps identify the source of infection and prevent outbreaks. Legionella is consumed by amoeba, multiplying from within before exploding, resulting in an outbreak. Due to this ongoing testing, combating the potential bacterial problems becomes essential. Legionella bacteria tend to grow in slime and biofilms on the surface of streams, lakes, and rivers. Low levels of the organism can colonize different water sources, growing in high concentrations under appropriate conditions.

Technological Advancements Boost Global Legionella Testing Market Growth

Various organizations and research institutes are investing in the development of advanced methods and devices to detect legionella due to the increasing prevalence of the various diseases caused by the bacteria. The traditional methods of monitoring the temperature of the water outlets have been seen to be economically inefficient, manual, and resource-intensive. Thus, the independent internet of things network operator Heliot Europe and Sigfox operators have initiated a partnership with Cistermiser for developing their LinkThru Temperature Monitoring Unit (TMU) devices. These devices have been developed for connecting to Heliot's Sigfox-0G network for IoT. After the device is connected to the pipework system, it harnesses internet of things technology for monitoring the flow and temperature of the water. The data is then captured in appropriate formats for regulators, allowing building owners to ensure compliance with HSG274 regulation in order to reduce the risk of legionella and other pathogens that are waterborne.

North America Accounts for Significant Market Share

The presence of an established healthcare infrastructure, strong water testing regulations, and increasing awareness about the disease are supporting the growth of the North America legionella testing market. The requirement for legionella testing is also propelling due to increasing vulnerability to infection and the expansion of the geriatric population. The regulatory agencies in the region, including the Environmental Protection Agency (EPA) and the Centers for Disease Control and Prevention (CDC), are implementing stringent regulations for monitoring water systems and guidelines for testing for legionella contamination. The presence of various leading market players in North America is further supporting the growth of the market in the region as they are increasing their efforts to introduce legionella testing kits to their portfolios. For instance, in 2021, Thermo Fisher introduced the qualyfast DNA extraction kit for detecting Legionella in clear water samples. The qualyfast Legionella PCR range provides environmental testing laboratories with a workflow that is capable of delivering accurate results within hours.

Urinary Antigen Test Accounts for Significant Global Legionella Testing Market Share

Urinary antigen tests allow for rapid identification of infections, allowing for earlier adoption of preventive measures and targeted therapies. The urinary antigen test is deployed for detecting the molecules of legionella bacterium in urine. Advancements in urinary antigen testing technologies to ensure the provision of reliable results in a time efficient manner are supporting segment expansion. The easy-to-perform and rapid nature of the test as compared to conventional methods is further bolstering their popularity. According to the article Evaluation of Four Lateral Flow Assays for the Detection of Legionella Urinary Antigen, published in Microorganisms journal, the overall specificity and sensitivity of legionella urinary antigen tests are 90.0-94.9% and 53.9-61.5%, respectively. The high specificity and sensitivity offered are propelling the utilization of urinary antigen test and augmenting the expansion of the segment.

Water Treatment Plants Expected to Witness Significant Growth

The rising requirement for legionella testing from water treatment plants is boosting the global legionella testing market size. The presence of legionella in commercial buildings and workplaces can be catastrophic, making testing for legionella an essential requirement. The bacteria are found in water and are inhaled through airborne droplets that are often created by cold or hot water systems. If inhaled, it can lead to legionnaires disease, one of the most fatal types of pneumonia. The risks presented by legionella make the testing of legionella in water systems and treatment plants essential. With the help of regular testing for legionella, potential and often fatal outbreaks of diseases caused by legionella can be prevented. Due to the growing population, investments towards water treatment plants are increasing, as they are essential for removing hazardous substances and contaminants from water and making it fit for drinking, among other applications. For instance, at present, Austin Water has three water treatment plants that draw water from the Colorado River and treat it to improve water quality and make it fit for drinking.

Future Market Scenario (2024-2031F)

According to the global legionella testing market analysis, the requirement for legionella testing will witness significant increase over the forecast period owing to the increasing need to minimize legionella growth in complex water systems to prevent infections. Due to the rapid expansion of the healthcare sector owing to increasing prevalence of chronic health conditions and rising population, the demand for legionella testing will increase from the sector as healthcare facilities are at a high risk of infection. The growing awareness about the threat of legionella and the risk of colonization in both cold and hot water systems will bolster the market demand in the coming years.

Key Players Landscape and Outlook

The key players in the legionella testing market are BioMerieux SA, Thermo Fisher Scientific Inc., Eurofins Scientific SE, Becton, Dickinson and Company, and Qiagen NV. The growth of the market will be augmented by increasing collaborations and acquisitions. In August 2022, IDEXX laboratories acquired TECTA-PDS, the Canadian water testing company. TECTA specializes in portable instruments that automatically test for enterococci, E. coli, and total coliforms. The TECTA B4 and B16 instruments are capable of providing rapid results to the laboratories. With this expansion, IDEXX expanded their microbiology testing options for in-field and lab-based testing.

Table of Contents

1.Research Methodology

2.Project Scope and Definitions

3.Executive Summary

4.Global Legionella Testing Market Outlook, 2017-2031F

• 4.1.Market Size & Forecast
  • 4.1.1.By Value
  • 4.1.2. By Volume
• 4.2.By Test Type
  • 4.2.1.Urinary Antigen Tests
  • 4.2.2.Direct Fluorescent Antibody Tests
  • 4.2.3.PCR
    • 4.2.3.1.Motorized Devices
    • 4.2.3.2.Non-Motorized Devices
  • 4.2.4.Culture Method
  • 4.2.5.Others
• 4.3.By Applications
  • 4.3.1.Environmental Testing
  • 4.3.2.Clinical Testing
• 4.4.By End-User
  • 4.4.1.Hospitals
  • 4.4.2.Clinics
  • 4.4.3.Diagnostic Laboratories
  • 4.4.4.Water Treatment Plants
  • 4.4.5.Others
• 4.5.By Region
  • 4.5.1.North America
  • 4.5.2.South America
  • 4.5.3.Europe
  • 4.5.4.Asia-Pacific
  • 4.5.5.Middle East and Africa
• 4.6.By Company Market Share (%), 2023

5.Global Legionella Testing Market Outlook, By Region, 2017-2031F

• 5.1.North America*
  • 5.1.1.Market Size & Forecast
    • 5.1.1.1.By Value
    • 5.1.1.2.By Volume
  • 5.1.2.By Test Type
    • 5.1.2.1.Urinary Antigen Tests
    • 5.1.2.2.Direct Fluorescent Antibody Tests
    • 5.1.2.3.PCR
      • 5.1.2.3.1.Motorized Devices
      • 5.1.2.3.2.Non-Motorized Devices
    • 5.1.2.4.Culture Method
    • 5.1.2.5.Others
  • 5.1.3.By Applications
    • 5.1.3.1.Environmental Testing
    • 5.1.3.2.Clinical Testing
  • 5.1.4.By End-User
    • 5.1.4.1.Hospitals
    • 5.1.4.2.Clinics
    • 5.1.4.3.Diagnostic Laboratories
    • 5.1.4.4.Water Treatment Plants
    • 5.1.4.5.Others
  • 5.1.5.United States*
    • 5.1.5.1.Market Size & Forecast
      • 5.1.5.1.1.By Value
      • 5.1.5.1.2.By Volume
    • 5.1.5.2.By Test Type
      • 5.1.5.2.1.Urinary Antigen Tests
      • 5.1.5.2.2.Direct Fluorescent Antibody Tests
      • 5.1.5.2.3.PCR
        • 5.1.5.2.3.1.Motorized Devices
        • 5.1.5.2.3.2.Non-Motorized Devices
      • 5.1.5.2.4.Culture Method
      • 5.1.5.2.5.Others
    • 5.1.5.3.By Applications
      • 5.1.5.3.1.Environmental Testing
      • 5.1.5.3.2.Clinical Testing
    • 5.1.5.4.By End-User
      • 5.1.5.4.1.Hospitals
      • 5.1.5.4.2.Clinics
      • 5.1.5.4.3.Diagnostic Laboratories
      • 5.1.5.4.4.Water Treatment Plants
      • 5.1.5.4.5.Others
  • 5.1.6.Canada
  • 5.1.7.Mexico

All segments will be provided for all regions and countries covered

• 5.2.Europe
  • 5.2.1.Germany
  • 5.2.2.France
  • 5.2.3.Italy
  • 5.2.4.United Kingdom
  • 5.2.5.Russia
  • 5.2.6.Netherlands
  • 5.2.7.Spain
  • 5.2.8.Turkey
  • 5.2.9.Poland
• 5.3.Asia-Pacific
  • 5.3.1.India
  • 5.3.2.China
  • 5.3.3.Japan
  • 5.3.4.Australia
  • 5.3.5.Vietnam
  • 5.3.6.South Korea
  • 5.3.7.Indonesia
  • 5.3.8.Philippines
• 5.4.South America
  • 5.4.1.Brazil
  • 5.4.2.Argentina
• 5.5.Middle East and Africa
  • 5.5.1.Saudi Arabia
  • 5.5.2.UAE
  • 5.5.3.South Africa

6.Market Mapping, 2023

• 6.1.By Test Type
• 6.2.By Applications
• 6.3.By End-User
• 6.4.By Region

7.Macro Environment and Industry Structure

• 7.1.Supply Demand Analysis
• 7.2.Import Export Analysis
• 7.3.Value Chain Analysis
• 7.4.PESTEL Analysis
  • 7.4.1.Political Factors
  • 7.4.2.Economic System
  • 7.4.3.Social Implications
  • 7.4.4.Technological Advancements
  • 7.4.5.Environmental Impacts
  • 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
• 7.5.Porter's Five Forces Analysis
  • 7.5.1.Supplier Power
  • 7.5.2.Buyer Power
  • 7.5.3.Substitution Threat
  • 7.5.4.Threat From New Entrant
  • 7.5.5.Competitive Rivalry

8.Market Dynamics

• 8.1.Growth Drivers
• 8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

• 9.1.Patent Landscape
• 9.2.Regulatory Approvals
• 9.3.Innovations/Emerging Technologies

10.Key Players Landscape

• 10.1.Competition Matrix of Top Five Market Leaders
• 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
• 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
• 10.4.SWOT Analysis (For Five Market Players)
• 10.5.Patent Analysis (If Applicable)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

• 13.1.BioMerieux SA
  • 13.1.1.Company Details
  • 13.1.2.Key Management Personnel
  • 13.1.3.Products and Services
  • 13.1.4.Financials (As reported)
  • 13.1.5.Key Market Focus and Geographical Presence
  • 13.1.6.Recent Developments
• 13.2.Thermo Fisher Scientific Inc.
• 13.3.Eurofins Scientific SE
• 13.4.Becton, Dickinson and Company
• 13.5.Qiagen NV
• 13.6.Aquacert Ltd.
• 13.7.Merck KgaA
• 13.8.Abbott Laboratories
• 13.9.Pro Lab Diagnostics Inc.
• 13.10.IDEXX Laboratories, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14.Strategic Recommendations

15.About Us & Disclaimer